Third-generation sequencing technologies, such as those developed by Oxford Nanopore Technologies and Pacific Biosciences, allow for the sequencing of long ... investigators can link suspects to ...

Revvity, Inc. (NYSE: RVTY), announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ...

Genetic sequencing has gone through several advances. A major breakthrough came when scientists began breaking the billions ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...

workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This ...

The cause of rare diseases is increasingly being detected through genome sequencing, which involves reading the entire human ...

PacBio (PACB) announced a significant publication from Radboud University Medical Center and its research partners in the American Journal of ...

Pacific Biosciences of California, Inc. PACB recently announced a significant publication from Radboud University Medical ...